The word on The Street in general, suggests a Strong Buy analyst consensus rating for JD Health International, Inc. with a HK$64.18 average price target.

Based on JD Health International, Inc.’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of HK$38.15 billion and a net profit of HK$2.78 billion. In comparison, last year the company earned a revenue of HK$29.82 billion and had a net profit of HK$2.12 billion